The study included 196 breast cancer patients with stages T1-3N0-3M0. The comprehensive therapy for breast cancer included surgical operation, chemotherapy, and radiotherapy. Multivariate analysis showed that multifocality growth of tumor (p = 0.004), high grade III (p = 0.008), two metastatic lymph nodes (p = 0.02) were associated with an increased risk of regional node failure in the patients with one to three positive lymph nodes. The prognostic models describing the probability of local recurrences of breast cancer were developed for individualization of the radiation therapy tactics. Postmastectomy radiation therapy in the patients with high-risk breast cancer treated with modified radical mastectomy improves locoregional control, breast cancer-specific survival, does not increase late toxicity.

1.
V. F.
Semiglazov
and
V. V.
Semiglazov
,
Practical Oncol.
9
(
1
),
9
15
(
2008
).
2.
M.
Overgaard
,
M. E.
Kvistgaard
, and
M. S.
Thomsen
,
Ugeskr. Laeger.
169
(
36
),
2993
2996
(
2007
).
3.
V. V.
Velikaya
,
L. I.
Musabaeva
,
V. A.
Lisin
, and
Zh. A.
Startseva
,
AIP Conf. Proc.
1760
,
020069
(
2016
).
4.
V. V.
Velikaya
,
L. I.
Musabaeva
,
Zh. A.
Startseva
, and
V. A.
Lisin
,
Vopros. Oncol.
61
(
4
),
583
585
(
2015
).
5.
Y. B.
Cihan
and
T.
Sarigoz
,
Onco. Targets. Ther.
9
,
5587
5595
(
2016
).
6.
I. A.
Miloichikova
,
A. A.
Krasnykh
,
I. B.
Danilova
,
S. G.
Stuchebrov
, and
V. A.
Kudrina
,
AIP Conf. Proc.
1772
(
1
),
060018
(
2016
).
7.
S. G.
Stuchebrov
,
I. A.
Miloichikova
, and
I. B.
Danilova
,
J. Phys. Conf. Ser.
671
(
1
),
012057
(
2016
).
8.
S. G.
Stuchebrov
,
I. A.
Miloichikova
, and
X. O.
Shilova
,
J. Phys. Conf. Ser.
671
(
1
),
012051
(
2016
).
9.
L. I.
Musabaeva
,
Zh. A.
Startseva
,
O. V.
Gribova
,
V. V.
Velikaya
, and
V. A.
Lisin
,
AIP Conf. Proc.
1760
,
020050
(
2016
).
10.
M. E
Taylor
,
B. G.
Haffty
,
R.
Rabinovitch
, et al.,
Int. J. Radiat. Oncol. Biol. Phys.
73
(
4
),
997
1002
(
2009
).
11.
M.
Clarke
,
R.
Collins
, and
S.
Darby
,
Lancet
366
(
9503
),
2087
2106
(
2005
).
12.
Zh. A.
Startseva
,
K. A.
Simonov
, and
E. M.
Slonimskaya
,
Vopros. Onkol.
5
,
778
781
(
2015
).
13.
Zh. A.
Startseva
,
K. A.
Simonov
, and
E. M.
Slonimskaya
,
Rad. Risk
23
(
2
),
102
111
(
2014
).
14.
N. S.
Russell
,
I. H.
Kunkler
, and
G.
van Tienhoven
,
Ann. Oncol.
26
(
6
),
1043
1044
(
2016
).
15.
R.
Sharma
,
I.
Bedrosian
,
A.
Lucci
, et al.,
Ann. Surg. Oncol.
17
,
2899
2908
(
2010
).
16.
K.
Sekiguchi
,
Breast Cancer
24
(
4
),
493
495
(
2017
).
17.
J.
Lin
,
C.
Li
,
C.
Zhang
,
F.
Shi
, and
H.
Wang
,
Future Oncology
(
2017
).
18.
H.
Wang
,
L.
Kong
,
C.
Zhang
,
D.
Chen
, and
H.
Zhu
,
Oncotarget
46
(
7
),
75492
75502
(
2016
).
19.
T. A.
Moo
,
R.
McMillan
,
M.
Lee
, et al.,
Ann. Surg. Oncol.
21
(
5
),
1569
1574
(
2014
).
20.
Z. Y.
He
,
S. G.
Wu
,
J.
Zhou
, et al.,
PLoS ONE
10
(
3
),
e0119105
(
2015
).
21.
H.
Shen
,
L.
Zhao
,
L.
Wang
, et al.,
Tumour Biol.
37
(
5
),
6465
6475
(
2016
).
This content is only available via PDF.
You do not currently have access to this content.